Smith & Nephew (SNN) Change in Inventory (2023 - 2024)

Smith & Nephew (SNN) posted quarterly Change in Inventory of -$119.0 million for Q4 2024, up 41.67% year-on-year from -$84.0 million in Q1 2024, and up 41.67% on a QoQ basis from -$204.0 million in Q4 2023.

Smith & Nephew (SNN) Change in Inventory (2023 - 2024) Analysis & Trends

Smith & Nephew (SNN) has reported Change in Inventory for 2 consecutive years, with -$119.0 million the latest figure, recorded in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 420.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 127.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -399.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 177.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 1.60 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 65.20 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -264.59 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 171.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn -38.50 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 -119.00 Mn
Dec 31, 2024 -119.00 Mn
Dec 31, 2023 -204.00 Mn
Dec 31, 2023 -204.00 Mn